KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Non-Current Deffered Revenue (2017 - 2025)

Cardlytics (CDLX) has disclosed Non-Current Deffered Revenue for 9 consecutive years, with $52000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deffered Revenue changed N/A year-over-year to $52000.0, compared with a TTM value of $52000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $52000.0, changed N/A over the prior year.
  • Non-Current Deffered Revenue was $52000.0 for Q4 2025 at Cardlytics, down from $62000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $334000.0 in Q4 2022 and bottomed at $30000.0 in Q2 2024.
  • Average Non-Current Deffered Revenue over 5 years is $101785.7, with a median of $78000.0 recorded in 2023.
  • The sharpest move saw Non-Current Deffered Revenue plummeted 79.94% in 2023, then skyrocketed 150.0% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $173000.0 in 2021, then surged by 93.06% to $334000.0 in 2022, then tumbled by 79.94% to $67000.0 in 2023, then crashed by 55.22% to $30000.0 in 2024, then surged by 73.33% to $52000.0 in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for CDLX at $52000.0 in Q4 2025, $62000.0 in Q3 2025, and $75000.0 in Q2 2025.